Riktad emission och lånekonverteringar till aktier om 13,6

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
222
Riktad emission och lånekonverteringar till aktier om 13,6 MSEK

Danderyd 7 september 2019

Riktad emission och lånekonverteringar till aktier om 13,6 MSEK

Copperstone förstärker sin finansiella position med ytterligare 13,6 MSEK genom en kombination av riktad emission och konverteringar av lån till aktier.

”Vi är glada åt våra nya investerare från Norrbotten, Stockholmsregionen, USA och Schweiz i samband med att vi påbörjar vårt nya borrprogram på Viscaria. Vi känner också betydande stöd från de finansiärer som valt att konvertera lån till aktier.”, kommenterar VD Michael Mattsson.

Transaktionen utgörs av följande delar:

31 675 488 aktier för 12 321 765 SEK i kontanta medel, varav cirka 5,69 MSEK kommer att användas till att amortera lån. 3 233 933 aktier motsvarande 1 258 000 SEK avser konvertering/kvittning av lån och räntor till aktier.

Emissionskurs är 0,389 SEK/aktie, vilket motsvarar en rabatt om 8,3% i förhållande till 5-dagars volymvägt genomsnittligt aktiepris t o m den 5 september 2019 på Nasdaq First North Growth Market. Totalt innebär därmed emissionerna en förstärkning av den finansiella position med 13 579 765 SEK, netto efter transaktionskostnader som uppgår till 0 SEK.

Efter transaktionen har brygglånen i Copperstone minskat från 11,8 MSEK till 5,5 MSEK.

Totalt antal utgivna aktier i emissionen är 34 909 421, vilket ökar aktiekapitalet i Copperstone med 3 490 942,1 SEK. Antal utestående aktier i Copperstone efter transaktionen uppgår till 517 252 676. Utspädningen uppgick till 6,7%.

”Genom denna riktade emission bygger Copperstone vidare på sitt momentum för återstart av Viscariagruvan i Kiruna, en världsklassort inom gruvindustrin. Vår balansräkning stärks och härtill kommer finansnettot att kraftigt förbättras, ” kommenterar VD Michael Mattsson.

För ytterligare information, vänligen kontakta Michael Mattsson, VD, +46 705 739 777, michael.mattsson@copperstone.se, info@copperstone.se eller besök Copperstones hemsida på www.copperstone.se

Detta pressmeddelande innehåller insiderinformation som Copperstone Resources AB (publ) är skyldig att offentliggöra enligt EU:s marknadsmissbruksförordning (MAR). Denna information lämnades genom ovannämnda kontaktpersons ombud, för offentliggörande den 7 september 2019 kl 20.30 CET.

Om Copperstone

Copperstone Resources AB är ett mineralprospekteringsbolag med ett mål att bli ett producerande bas- och ädelmetallföretag inom 3 till 5 år. Bolaget innehar ett antal bearbetningskoncessioner och undersökningstillstånd i Kiruna (Viscariagruvan), Arvidsjaur (Copperstoneprojektet) och Smedjebacken (Tvistbogruvan) samtliga i Sverige. Största delen av Bolagets mineraltillgångar utgörs f n av koppar. Tillstånd finns även avseende zink, guld, silver och bly m m. Härutöver finns intressen inom järnmalm (Viscaria och konvertibel i Nordic Iron Ore AB). Samtliga undersökningstillstånd och bearbetningskoncessioner är ägda till 100 %, direkt eller indirekt. Bolagets aktie är föremål för handel på Nasdaq First North Growth Market (ticker COPP B). Augment Partners är bolagets Certified Adviser, info@augment.se , +46 8 505 65 172.

 

 

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 401

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 239

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 659

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 157

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 508

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 499

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 281

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 440

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 253

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 282

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading

Top 5 Most Recently Viewed Articles

Antengene's XPOVIO® Gains Approval in Thailand for Cancer Treatment

Updated Category News Views 114

Antengene's Recent Approval of XPOVIO® in Thailand Antengene Corporation Limited, a distinguished global biopharmaceutical company, has reached a notable achievement with the approval of XPOVIO® (selinexor) by the Thailand Food and Drug Administration. This approval marks XPOVIO® as the first and only XPO1 inhibitor authorized for sale in the Thai market. The drug,...

Continue Reading
Monumental Pediatric Surgery Advances at Nicklaus Children

Updated Category News Views 23

Redefining Pediatric Surgery with Mixed Reality Cue the drumroll, because Nicklaus Children's Hospital in Miami just pulled off a doozy in the medical field. The region's first pediatric total hip replacement using mixed reality-assisted guidance has taken place, and the ripples from this bad boy could be significant. The Hero of the Hour: Dr. Thomas J. Utset-Ward Dr....

Continue Reading
Contrasting Luxury Real Estate Trends in the U.S. Market

Updated Category News Views 151

The Evolving Landscape of U.S. Luxury Real Estate In the world of luxury real estate, change is the only constant. A recent report sheds light on how the U.S. luxury housing market is adapting to buyer preferences, with 2026 marking an interesting phase in pricing stabilization. Nationally, entry-level luxury prices stand steady at $1.19 million, but the interpretation of...

Continue Reading
Bureau Veritas Explores Potential Merger with SGS

Updated Category News Views 325

Exploring Business Synergies: Bureau Veritas and SGS Recent media discussions have shed light on the evolving landscape of Bureau Veritas as it engages in talks with SGS about the possibility of a business merger. This potential union reflects the growing trend within industries to enhance competencies and create greater value through collaboration. Bureau Veritas, a...

Continue Reading
Equifax Engages Investors in September Conferences Overview

Updated Category News Views 133

Equifax Invites Investors to Upcoming Conferences Equifax®, a leading data, analytics, and technology company recognized by its stock symbol EFX on the NYSE, is gearing up to engage with investors through several key conferences this September. This month presents an excellent opportunity for investors to gain insights into the company's strategy and future direction....

Continue Reading